Is the Monthly Sublocade Treatment Program Right for You?

Is the Monthly Sublocade Treatment Program Right for You?

You may already be familiar with buprenorphine tablets or films, but a monthly sublocade treatment program can streamline your maintenance therapy by delivering a steady dose of medication without daily dosing. By shifting to a once-monthly injectable, you reduce the burden of daily pills, improve adherence, and focus on your recovery journey rather than your next dose. In this article, you’ll learn how sublocade works, what benefits and risks it carries, and how to integrate it into a comprehensive care plan.

You’ll also see how this long-acting injectable treatment stacks up against other options such as Vivitrol, and how to navigate insurance, find a qualified provider, and prepare for your first injection appointment. Whether you’re transitioning from another form of buprenorphine or starting medication-assisted treatment (MAT) for the first time, the information here will help you decide if a monthly injectable program fits your goals.

Understanding monthly Sublocade

What this program entails

A monthly sublocade maintenance plan involves a prefilled syringe of long-acting buprenorphine injected under the skin by your healthcare provider. Each dose delivers a controlled amount of buprenorphine over roughly 30 days, so you avoid daily self-administration and the risk of missed doses.

How buprenorphine release works

The injectable uses a polymer base that slowly dissolves after subcutaneous administration, releasing buprenorphine into your bloodstream. This steady release helps:

  • Keep opioid receptors partially stimulated to reduce cravings
  • Prevent full agonists like heroin or fentanyl from binding
  • Ease withdrawal symptoms without producing strong euphoria

This mechanism contrasts with daily formulations, which can cause peaks and troughs in drug levels.

Clinical success rates

Clinical trials show a clear benefit when you combine monthly injections with counseling. In one study, 28 percent of patients on Sublocade plus therapy achieved treatment success, compared with 2 percent on placebo plus counseling [1]. Another 24-week trial found about 30 percent of participants remained opioid-free for at least 80 percent of the study period when receiving monthly injections alongside behavioral support [2].

Exploring treatment benefits

Consistent dosing schedule

With a structured injection calendar—two initiation doses followed by monthly maintenance—you gain predictability. Your second shot can come as soon as one week after the first or up to four weeks later to build therapeutic levels faster. After those two loading doses, injections every 26–30 days maintain stable blood levels.

Reduced cravings and relapse

By occupying opioid receptors steadily, you minimize the “ups and downs” that can trigger cravings. That pharmacologic blockade also lowers the chance of experiencing a high from illicit opioids, reinforcing your commitment to sobriety.

Same-day start option

Even if you’ve never taken buprenorphine before, you may qualify for an immediate initiation protocol. A same-day start ensures you begin treatment without lengthy pre­treatment requirements or waiting periods [1]. This rapid access can be critical if you’re at high risk of relapse.

Focus on daily life

Eliminating daily dosing lets you invest time and energy in therapy, work, family, or hobbies instead of managing medication schedules. Many patients report reduced stress around dosing logistics, which supports long-term engagement in recovery.

Considering safety and side effects

Common side effects

Most reactions are mild and tend to fade as your body adjusts. Typical issues include:

  • Constipation
  • Nausea or vomiting
  • Headache
  • Drowsiness or fatigue
  • Muscle aches

Serious risks and monitoring

Though rare, severe events require prompt attention:

Side effect Frequency Notes
Respiratory depression Rare Seek emergency care immediately [3]
Severe allergic reaction Rare Discontinue and call 911
Liver function abnormalities Rare Regular liver tests recommended [4]
Opioid-induced androgen deficiency Rare May lower testosterone after high doses
Central nervous system depression Rare Avoid other depressants

You should also have naloxone on hand in case of unexpected breathing issues [3]. Always report persistent or worsening symptoms to your provider.

Coordinating with counseling

Importance of integrated care

Medication-assisted treatment is most effective when paired with behavioral therapy. Counseling helps you develop coping strategies, address underlying triggers, and build a relapse prevention plan. Evidence shows combining monthly injections with therapy leads to better outcomes than medication alone.

Accessing therapy programs

Carolina Energetics offers a full continuum of care that links your injections with individual and group counseling. You can learn more about how we blend medication and psychotherapy in our sublocade and counseling integration services.

Comparing Vivitrol program

Medication differences

  • Sublocade: Buprenorphine partial agonist, reduces cravings and blocks other opioids
  • Vivitrol: Naltrexone antagonist, requires full detox before initiation

Suitability and eligibility

If you can wait 7–10 days after your last opioid dose, you may start an injectable naltrexone regimen through our vivitrol program outpatient clinic. For direct coverage details, see insurance covered vivitrol injection. Sublocade may suit you if you seek a same-day start and want active symptom relief.

Private insurance and Medicaid

The Mental Health Parity and Opioid dependency Equity Act of 2008 ensures most insurers cover medication-assisted treatments like Sublocade [5]. Many state Medicaid plans also include monthly injections as a benefit.

Verification and support

Our team can confirm your benefits, co-pays, and prior authorization requirements through our sublocade insurance verification support and our insurance verified injectable mat program. We also assist with Medicaid cases—learn about our sublocade appointment covered by medicaid process.

Finding a provider

In-person clinics and telehealth

You can receive injections on site at Carolina Energetics or via our telehealth follow-up model. To set up a remote appointment, visit telehealth sublocade appointment setup. If you prefer an in-person facility closer to home, search for a local office using our sublocade treatment provider near me tool.

Questions to ask your provider

Before starting, consider clarifying:

  1. Which dose schedule fits my history and needs?
  2. How will we monitor side effects and lab work?
  3. What counseling or peer support do you recommend?
  4. How do we handle missed or delayed injections?

Having these answers ahead of time will make your program smoother.

Taking next steps

Preparing for your first visit

  • Confirm your insurance coverage and any authorizations
  • Arrange transportation—you may feel drowsy afterward
  • Compile your medical history, including past treatments and current medications

Maintaining monthly plan

  • Schedule your injections 26–30 days apart
  • Keep all counseling appointments
  • Monitor symptoms and side effects
  • Stay engaged with peer support or recovery groups

A successful monthly injectable program relies on consistent follow-up and open communication with your care team. If you’re ready to streamline your medication regimen and focus on lasting recovery, contact Carolina Energetics today to discuss whether a sublocade maintenance plan is right for you.

References

  1. (Sublocade)
  2. (Achieve Whole Recovery)
  3. (WebMD)
  4. (Boca Recovery Center)
  5. (American opioid dependency Centers)

Start Your Healing Journey with Carolina Energetics PC

Ready to begin your path to recovery? Contact us now to schedule a consultation and experience the difference of personalized, professional care in a welcoming environment.

Office Hours
Blood Testing Hours
Urine Testing Hours

Save Buprenorphine

Buprenorphine is under threat—and so are the patients who depend on it.

This life-saving medication is now listed as a “suspicious drug,” leading many pharmacies to stop dispensing it altogether. The DEA is pushing for everyone to switch to Buprenorphine/Naloxone (Suboxone), but not every patient can tolerate Naloxone. Many experience severe side effects or have legitimate sensitivity—even when allergy tests fail to detect it.

We’ve seen firsthand the damage this policy shift is causing.

We need your voice. Congressmen Paul Tonko and Senator Martin Heinrich are sponsoring a bill to protect access to Buprenorphine, and bipartisan support is growing. We urge you to contact your state Senators and President Trump online to support this bill. Your advocacy could help restore patient choice and save lives.

Don’t let politics get in the way of proper care. Help us protect access to Buprenorphine.